High-quality Syloid® Xdp 3150 Silica : Turn Distillate To Powder (fda Approved Ingredient) Holiday Edition [Od2ph0gY]

Syloid® XDP 3150 Silica: Turn Distillate to Powder

Introducing Syloid® XDP 3150 Silica, the ultimate solution for transforming your distillate into a powdered ingredient. This innovative product is designed for lipid-based drug delivery systems, offering a seamless conversion process that enhances the convenience and effectiveness of your formulations. With its FDA-approved status, Syloid® XDP 3150 Silica is a trusted choice for pharmaceutical and nutraceutical industries.

Properties and Specifications

Syloid® XDP 3150 Silica is a high purity silica gel, consisting of over 99% SiO2. It meets the stringent ICH guidelines on elemental impurities and adheres to the test requirements of the U.S. Pharmacopoeia-National Formulary and European Pharmacopoeia for Silica, Colloidal Hydrated. The product is labeled with CAS # 7631-86-9, amorphous silica gel or silicon dioxide, and is an approved FDA Database inactive ingredient, suitable for drug products.

Practical Uses and Benefits

Syloid® XDP 3150 Silica is versatile and can be used in a variety of applications. Whether you're creating capsules, chewable tablets, gummy products, chocolates, or drinks, this product ensures a consistent and accurate dosage. The recommended ratio of 1:1 weight (distillate to SYLOID) simplifies batching and recipe replication, making it accessible for both experts and beginners. Key benefits include its ability to stay in suspension for edibles, delivering an equal dose in each serving, and optimizing bioavailability. With Syloid® XDP 3150 Silica, you can achieve complete release of your active ingredients, ensuring maximum efficacy and patient satisfaction.